Olopatadine Hydrochloride Solution
Product Images NDC 0363-0200

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Olopatadine Hydrochloride (NDC 0363-0200). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Walgreen Co., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel-0.1% (5 mL Container) (Olopatadine Fig1)

This is a Walgreens eye drop product for allergy relief. The active ingredient is OLOPATADINE HYDROCHLORIDE OPHTHALMIC SOLUTION USP, 0.1%, which acts as an antihistamine and redness reliever. The product is only for use in the eye and is sterile. The packaging size is 5 mL (0.7 FL0D) and should be stored between 4° to 25°C (39° to 77°F). The product comes with a tamper-evident cap and a satisfaction guarantee from Walgreens. The text also includes a distributor address, a product code, as well as a disclaimer that it is made in India.*

FDA Label Image

Package Label-principal Display Panel-0.1% (5 mL Container Carton) (Olopatadine Fig2)

This is a Drug Facts sheet for Olopatadine Hydrochloride Ophthalmic Solution used for relief from eye allergy and redness. The medication contains 0.1% of the active ingredient Optate and some other inactive ingredients. The sheet provides crucial information on directions of use, warnings, precautions, contraindications, and possible side effects that users may experience. Users are asked to avoid using the product if they are sensitive to any of the ingredients. The sheet further urges users to contact a physician if the condition worsens or persists. The product is suitable for adults and children aged two and above.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.